跳至主要内容
临床试验/NCT03414528
NCT03414528招募中不适用

Towards Identification of New Inborn Errors of Immunity by Whole Exome/Genome Sequencing

University of Zurich2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2015年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
2
主要终点
Identification of the genetic defects

研究概览

简要总结

Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing.

Transcriptome analysis of patients with molecularly undetermined PID.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with primary immunodeficiency (PID)
  • Male and Female participants 0 years to adult age (any)
  • Written informed consent by the participant after information about the research project

排除标准

  • Secondary immunodeficiency
  • Refusal to enter the study

研究组 & 干预措施

Patients with PID

干预措施: Diagnostic Test (Diagnostic Test)

结局指标

主要结局

Identification of the genetic defects

时间窗: 10 years

Whole exome/Genome sequencing will be done to identify new mutations leading to immunodeficiency

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janine Reichenbach

Co-Head Division Immunology

University of Zurich

研究点 (2)

Loading locations...

相似试验